Slower gait speed, but not handgrip strength or muscle mass, is associated with an increased risk for cardiovascular outcomes ...

Heart transplant is a scary and serious surgery with a high cost, but for patients with heart failure it can be the only ...

India's first heart failure registry reveals younger patients, high mortality rates, and varying causes of heart failure.

Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...

New research explores how point-of-care lung ultrasound can improve prehospital identification of acute heart failure ...

Blockages in coronary arteries cause sudden heart attacks, leading to heart muscle damage. In contrast, heart failure is a ...

A multi-institutional research team led by Osaka University found that tricaprin, a natural supplement, improved long-term ...

Using the BiovitalsHF software to personalize recommendations got more patients on all four pillars of therapy.

A novel transcatheter-implanted system that shunts blood flow from the left to right atrium through the coronary sinus has ...

Infection-related hospitalization (IRH) is associated with incident heart failure, heart failure with preserved ejection ...

Recent reports reveal heart disease is the leading cause of death in the U.S., many of whom are younger than 45. Here's what ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...